Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: Methods, baseline fields, and six-month longitudinal follow-up

Transactions of the American Ophthalmological Society

Volumn 102, Issue , 2004, Pages 269-303

  Feldon, Steven E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL SCOTOMA; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SYSTEM; CONTROLLED STUDY; DECOMPRESSION SURGERY; DISEASE SEVERITY; FOLLOW UP; HUMAN; NERVE SHEATH; OPTIC NERVE DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; VALIDATION PROCESS; VISUAL FIELD DEFECT; AGED; AUTOMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXPERT SYSTEM; HOSPITALIZATION; ISCHEMIC OPTIC NEUROPATHY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIMETRY; RANDOMIZED CONTROLLED TRIAL; STANDARD; VALIDATION STUDY; VISUAL DISORDER; VISUAL FIELD;

AGED; AUTOMATION; DECOMPRESSION, SURGICAL; EXPERT SYSTEMS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PERIMETRY; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; VISION DISORDERS; VISUAL FIELDS;

EID: 17244370437     PISSN: 15456110     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ischemic Optic Nerve Decompression Trial Group. The Ischemic Optic Neuropathy Decompression Trial (IONDT): design and methods. Control Clin Trials 1998;19:276-296.
2. Ischemic Optic Nerve Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273:625-632.
3. Keltner JL, Johnson CA, Beck RW, et al. Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). Control Clin Trials 1995;14:143-159.
4. Katz J, Congdon N, Friedman D. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol 1999:117:1137-1142.
5. Molino G, Marzuoli M, Molino F, et al. Validation of ICTERUS, a knowledge-based expert system for jaundice diagnosis. Methods Inf Med 2000;39:311-318.
6. Hernandez C, Sancho JJ, Belmonte MA, et al. Validation of the medical expert system RENOIR. Comput Biomed Res 1994;27:456-471.
7. Sutton GC. How accurate is computer-aided diagnosis? Lancet 1989;2:905-908.
8. Werner EB, Saheb N, Thomas D. Variability of static visual threshold responses in patients with elevated IOPs. Arch Ophthalmol 1982;100:1627-1631.
9. Keltner JL, Johnson CA, Quigg JM, et al, for the Ocular Hypertension Treatment Study Group. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol 2000;118:1187-1194.
10. Katz J. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology 1999;106:391-395.
11. de la Rosa MG, Reyes JAA, Sierra MAG. Rapid assessment of the visual field in glaucoma using an analysis based on multiple correlations. Graefes Arch Clin Exp Ophthalmol 1990;228:387-391.
12. McNaught AI, Crabb DP, Fitzke FW, et al. Modelling series of visual fields to detect progression in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1995;233:750-755.
13. Keltner JL, Johnson CA, Spurr JO, et al, Optic Neuritis Study Group. Baseline visual field profile of optic neuritis; the experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1993;111:231-234.
14. Keating D, Mutlukan E, Evans A, et al. A back propagation neural network for the classification of visual field data. Phys Med Biol 1993;38:1263-1270.
15. Brigatti L, Hoffman D, Caprioli J. Neural networks to identify glaucoma with structural and functional measurements. Am J Ophthalmol 1996;121:511-521.
16. Goldbaum MH, Sample PA, Chan K, et al. Comparing machine learning classifiers for diagnosing glaucoma from standard automated perimetry. Invest Ophthalmol Vis Sci 2002;43:162-169.
17. Kelman SE, Perell HF, D'Autrechy L, et al. A neural network can differentiate glaucoma and optic neuropathy visual fields through pattern recognition. In: Mills RP, Heijl A, ed. Perimetry Update 1990/91. Proceedings of the Sixth International Perimetric Society Meeting, Malmo, Sweden, June 17-20, 1990. Amsterdam/New York: Kugler Publications; 1991:287-290.
18. Henson DB, Spenceley SE, Bull DR. Spatial classification of glaucomatous visual field loss. Br J Ophthalmol 1996;80:526-531.
19. Hirsbrunner H-P, Fankhauser F, Jenni A, et al. Evaluating a perimetric expert system: experience with Octosmart. Graefes Arch Clin Exp Ophthalmol 1990;228:237-241.
20. Ellenberger C, Keltner JL, Burde RM. Acute optic neuropathy in older patients. Arch Ophthalmol 1973;28:182-185.
21. Eagling EM, Sanders MD, Miller SJH. Ischemic papillopathy: clinical and fluorescein angiographic review of forty cases. Br J Ophthalmol 1974;58:990-1008.
22. Miller GR, Smith JL. Ischemic optic neuropathy. Am J Ophthalmol 1966;62:103-115.
23. Cullen JF. Ischemic optic neuropathy. Trans Ophthalmol Soc U K 1967;87:759-774.
24. Repka MX, Savino PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983;96:478-483.
25. Hayreh SS, Podhajsky P. Visual field defects in anterior ischemic optic neuropathy. Doc Ophthalmol Proc Ser 1979;19:53-71.
26. Traustason OI, Feldon SE, Leemaster JE, et al. Anterior ischemic optic neuropathy: classification of field defects by Octopus automated static perimetry. Graefes Arch Clin Exp Ophthalmol 1988;226:206-212.
27. Guyer DR, Miller NR, Auer CL, et al. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985;103:1136-1142.
28. Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;118:766-780.
29. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol 1997;115:1403-1407.
30. Newman NJ, Scherer R, Langenberg P, et al; Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317-328.
31. Johnson C. Ocular Hypertension Treatment Study - determination of progression. In: Anderson DR, Drance SM, ed. Encounters in Glaucoma Research 3: How to Ascertain Progression and Outcome. Amsterdam/New York: Kugler Publications; 1996:165-182.
32. Keltner JL, Johnson CA, Quigg JM, et al, for the Ocular Hypertension Treatment Study Group. Confirmation of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol 2000;118:1187-1194.
33. Sergott RC, Cohen MS, Bosley TM, et al. Optic nerve sheath decompression may improve the progressive form of ischemic optic neuropathy. Arch Ophthalmol 1989;107:1743-54.
34. WuDunn D, Zimmerman K, Sadun AA, et al. Comparison of visual function in fellow eyes after bilateral nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1997;104:104-111.
35. Boone MI, Massry GG, Frankel RA, et al. Visual outcome in bilateral nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1996;103:1223-1228.
36. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2001;132:734-742.
37. Fang JP, Lin RH, Donahue SP. Recovery of visual field function in the optic neuritis treatment trial. Am J Ophthalmol 1999;128:566-572.
38. Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 1991;14:66-69.